Vaping harms awareness messaging: exploring young South Australians' responses to vaping prevention campaign materials.

electronic nicotine delivery devices health communication prevention vaping

Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 14 11 2023
pubmed: 12 11 2023
entrez: 12 11 2023
Statut: ppublish

Résumé

Nicotine vaping products (NVPs) pose health risks associated with nicotine dependence and increased likelihood of tobacco consumption. Despite having a secondary role in smoking cessation, recreational NVP use is increasing among younger people. Vaping prevention campaigns aim to influence views on the health risks of vaping. This study examined perceptions of Australian and international vaping prevention campaigns among 27 young South Australians aged 16-26 years who do and do not use NVPs, to inform targeting and framing of vaping risk messaging. Participants viewed example materials from three vaping prevention campaigns: 'Epidemic', 'Do you know what you're vaping' and 'Unveil what you inhale'. Focus groups and interviews assessed whether materials were easily understood, appropriate, relevant, credible and effective in health communication. Participants indicated that all campaigns would influence their thoughts and actions related to vaping. The 'Do you know what you're vaping' campaign prompted thoughts about uncertainty about individual health risks, though participants did not indicate that this was enough to motivate vaping cessation. Participants considered the 'Unveil' campaign effective, with those who did not vape indicating they would click through to access resources, and those who did vape responding well to the 'challenge' aspect of the messaging. The 'Epidemic' campaign fear appeal did not clearly prompt change in vaping views or behaviours. Campaigns using a challenge approach may generate conversation about vaping harms, while fear appeals can be dismissed by younger audiences. Evidence-based short messages and the presentation of multiple versions of content were considered effective approaches.

Identifiants

pubmed: 37952201
pii: 7413076
doi: 10.1093/heapro/daad145
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Drug and Alcohol Services
ID : 2022-09636

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Joshua Trigg (J)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.

Ola Ela (O)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.

Jacqueline Bowden (J)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.
National Centre for Education and Training on Addiction, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.

Ashlea Bartram (A)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.
National Centre for Education and Training on Addiction, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.

Clinton Cenko (C)

Tobacco Control Unit, Drug and Alcohol Services South Australia, SA Health, (Kaurna) Stepney, South Australia 5069, Australia.

Billie Bonevski (B)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, (Kaurna) Bedford Park, South Australia 5042, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH